Skip to main content

FDA panel to review Pfizer and Moderna vaccines for children aged six month to 4 years on June 15

The Food and Drug Administration said Monday an advisory panel would meet June 15 to discuss use of the vaccines developed by Pfizer and German partner BioNTech, as well as the one developed by Moderna, in children aged 6 months to four years old.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.